CO · Healthcare

Bavarian Nordic (BAVA)

Biotechnology

Bavarian Nordic (BAVA) is listed on CO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $15.07B, P/E ratio is 13.06, net margin is 19.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for BAVA

Market cap
$15.07B
P/E ratio
13.06
Gross profit (TTM)
$2.87B
Net margin
19.7%

Bavarian Nordic (BAVA) — FAQ

What is Bavarian Nordic's market cap?

Bavarian Nordic (BAVA) has a reported market cap of $15.07B (data as of 2026-05-24).

What is BAVA's P/E ratio?

The price-to-earnings (P/E) ratio for Bavarian Nordic (BAVA) is 13.06 (data as of 2026-05-24).

Does Bavarian Nordic pay a dividend?

Dividend yield is not available in the current snapshot for Bavarian Nordic (BAVA). Check the MyAverix Finance app for the latest dividend data.

What sector is Bavarian Nordic in?

Bavarian Nordic (BAVA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BAVA listed on?

BAVA is listed on CO.

What is Bavarian Nordic's net margin?

Bavarian Nordic (BAVA) reports a net margin of 19.7% (data as of 2026-05-24).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play